Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumors

Most pancreatic neuroendocrine tumors (PNETs) do not produce excess hormones and are therefore considered ‘non-functional’(1–3). As clinical behaviors vary widely and distant metastases are eventually lethal(2,4), biological classifications might guide treatment. Using enhancer maps to infer gene re...

Descripción completa

Detalles Bibliográficos
Autores principales: Cejas, Paloma, Drier, Yotam, Dreijerink, Koen M. A., Brosens, Lodewijk A. A., Deshpande, Vikram, Epstein, Charles B., Conemans, Elfi B., Morsink, Folkert H. M., Graham, Mindy K., Valk, Gerlof D., Vriens, Menno R., Fernandez-del Castillo, Carlos, Ferrone, Cristina, Adar, Tomer, Bowden, Michaela, Whitton, Holly J., Da Silva, Annacarolina, Font-Tello, Alba, Long, Henry W., Gaskell, Elizabeth, Shoresh, Noam, Heaphy, Christopher M., Sicinska, Ewa, Kulke, Matthew H., Chung, Daniel C., Bernstein, Bradley E., Shivdasani, Ramesh A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6919319/
https://www.ncbi.nlm.nih.gov/pubmed/31263286
http://dx.doi.org/10.1038/s41591-019-0493-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6919319/
https://www.ncbi.nlm.nih.gov/pubmed/31263286
http://dx.doi.org/10.1038/s41591-019-0493-4

Ejemplares similares